RARA and acute promyelocytic leukemia: It seems likely that a further understanding of the pathogenesis of the RAS and its prevention, as well as better strategies for the treatment of the consumptive coagulopathy of APL, will evolve from an improved understanding of the biological properties of the fusion proteins of RAR-alpha.82